KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,100,036 | -50.6% | 233,621 | -50.0% | 0.03% | -48.1% |
| Q2 2023 | $54,847,872 | +8.3% | 467,188 | -26.2% | 0.05% | +5.9% |
| Q1 2023 | $50,663,889 | -6.3% | 632,824 | -7.3% | 0.05% | -10.5% |
| Q4 2022 | $54,097,753 | +14.4% | 682,880 | +0.6% | 0.06% | +7.5% |
| Q3 2022 | $47,289,000 | +2.5% | 678,470 | -3.5% | 0.05% | +10.4% |
| Q2 2022 | $46,153,000 | -8.5% | 702,903 | -7.3% | 0.05% | +11.6% |
| Q1 2022 | $50,427,000 | -4.3% | 757,859 | +0.6% | 0.04% | +53.6% |
| Q4 2021 | $52,719,000 | +30.8% | 753,680 | -2.4% | 0.03% | +27.3% |
| Q3 2021 | $40,304,000 | -22.7% | 771,954 | +0.7% | 0.02% | -21.4% |
| Q2 2021 | $52,111,000 | -13.2% | 766,325 | -1.7% | 0.03% | -9.7% |
| Q1 2021 | $60,043,000 | +29.0% | 779,400 | +0.5% | 0.03% | +34.8% |
| Q4 2020 | $46,532,000 | +39.6% | 775,528 | +0.2% | 0.02% | +15.0% |
| Q3 2020 | $33,332,000 | +17.9% | 774,254 | +13.4% | 0.02% | 0.0% |
| Q2 2020 | $28,272,000 | +12.6% | 682,544 | +17.6% | 0.02% | -9.1% |
| Q1 2020 | $25,098,000 | +61.5% | 580,436 | +106.8% | 0.02% | +100.0% |
| Q4 2019 | $15,540,000 | +561.8% | 280,618 | +314.9% | 0.01% | +450.0% |
| Q3 2019 | $2,348,000 | -15.8% | 67,637 | -2.3% | 0.00% | 0.0% |
| Q2 2019 | $2,787,000 | – | 69,212 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |